Delivery Order SPE2DB22D3501-SPE2DB25FVP08
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,965.97 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on September 2, 2025, with completion expected by September 3, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment, representing a specialized...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $15,826.78. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by June 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,105.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price, competitively awarded contract (non-set-aside) was executed on June 27, 2025, with an ultimate completion date of June 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used for osteoarthritis treatment, indicating...
- The Defense Logistics Agency awarded a $6,112.30 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract requires performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a non-set-aside procurement action for this injectable pharmaceutical product used in joint pain treatment and osteoarthritis management. This...
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,618.97 for Durolane 60 mg/3 ml syringes on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,232.37 for Durolane 60 mg/3 ml syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-use procurement of the injectable hyaluronic acid product, which is commonly used for osteoarthritis...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,275.20 firm fixed-price delivery order for Durolane 60 mg/3 ml syringes on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive, non-set-aside award is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVP08Delivery Order
The Defense Logistics Agency awarded a $6,375.69 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on May 6, 2025, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a viscosupplement injection used for osteoarthritis treatment, reflecting the Defense Logistics Agency Medical Supply Chain's procurement of specialized pharmaceutical and medical products to support military and veteran healthcare systems. This delivery order represents a task against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability in fulfilling federal medical procurement requirements through multiple competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 5/6/25 |